Andrew Huberman on CJC-1295
Andrew Huberman has publicly discussed CJC-1295 on multiple occasions. Andrew Huberman discusses CJC-1295 paired with Ipamorelin for synergistic GH release, with detailed explanations of the underlying neuroscience. This page examines what Andrew Huberman said, the specific sources, and how these statements compare to the available research.
"Growth hormone peptides should be taken before bed to align with the natural nocturnal GH pulse."
What Andrew Huberman Discussed
Discusses CJC-1295 paired with Ipamorelin for synergistic GH release, with detailed explanations of the underlying neuroscience.
Combined with Ipamorelin before bed
What Research Shows About CJC-1295
How CJC-1295 Works
CJC-1295 mimics GHRH to stimulate sustained growth hormone production from the pituitary. The DAC version binds albumin for extended half-life, while the no-DAC version produces pulsatile GH release more similar to natural physiology.
Research Summary
Clinical studies demonstrate dose-dependent GH elevation (2-10 fold) and IGF-1 increase (1.5-3 fold). Well-characterized pharmacokinetics for both versions.
Standard Dosage Information
No DAC: 100mcg 2-3 times daily with Ipamorelin. With DAC: 2mg once or twice weekly. Timing before bed or morning.
Important Considerations
- !Andrew Huberman discussed this peptide from personal experience or professional perspective, not as medical advice
- !Individual responses vary based on health status and genetics
- !Always consult a healthcare professional before any peptide protocol
- !Water retention and joint discomfort possible with sustained GH elevation
Frequently Asked Questions
What has Andrew Huberman said about CJC-1295?
Andrew Huberman has publicly discussed CJC-1295 in interviews, podcasts, or social media. Their comments reflect personal experience or professional observations, not medical recommendations. See the quotes and sources above for specific statements.
Should I follow Andrew Huberman's CJC-1295 protocol?
Celebrity protocols are not medical advice. Andrew Huberman's experience with CJC-1295 is individual and may not apply to your health situation. Always consult a qualified healthcare professional before considering any peptide protocol.
Is CJC-1295 safe based on what Andrew Huberman has discussed?
Andrew Huberman's positive experience does not establish safety. CJC-1295's safety profile depends on the specific compound, dosing, individual health status, and potential drug interactions. Celebrity experiences cannot replace clinical evidence and medical supervision.